2018 Q2 Form 10-Q Financial Statement

#000109714918000029 Filed on August 02, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $490.3M $356.5M
YoY Change 37.54% 32.34%
Cost Of Revenue $124.7M $85.57M
YoY Change 45.71% 33.39%
Gross Profit $365.6M $270.9M
YoY Change 34.94% 32.02%
Gross Profit Margin 74.56% 76.0%
Selling, General & Admin $212.1M $163.0M
YoY Change 30.14% 34.16%
% of Gross Profit 58.01% 60.15%
Research & Development $30.80M $24.38M
YoY Change 26.33% 31.01%
% of Gross Profit 8.43% 9.0%
Depreciation & Amortization $12.63M $8.876M
YoY Change 42.32% 74.28%
% of Gross Profit 3.46% 3.28%
Operating Expenses $242.9M $187.3M
YoY Change 29.65% 33.74%
Operating Profit $122.7M $83.57M
YoY Change 46.81% 28.3%
Interest Expense $1.900M $3.200M
YoY Change -40.63% 3100.0%
% of Operating Profit 1.55% 3.83%
Other Income/Expense, Net -$7.099M $1.771M
YoY Change -500.85% 1316.8%
Pretax Income $117.5M $86.78M
YoY Change 35.41% 32.98%
Income Tax $7.700M $15.39M
% Of Pretax Income 6.55% 17.73%
Net Earnings $106.1M $69.18M
YoY Change 53.38% 37.95%
Net Earnings / Revenue 21.64% 19.41%
Basic Earnings Per Share $1.32 $0.86
Diluted Earnings Per Share $1.30 $0.85
COMMON SHARES
Basic Shares Outstanding 80.22M shares 80.19M shares
Diluted Shares Outstanding 81.47M shares 81.63M shares

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $712.6M $602.0M
YoY Change 18.38% 5.27%
Cash & Equivalents $548.0M $358.2M
Short-Term Investments $164.6M $243.8M
Other Short-Term Assets $126.8M $74.40M
YoY Change 70.43% 96.31%
Inventory $47.25M $35.13M
Prepaid Expenses
Receivables $374.4M $291.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.261B $1.003B
YoY Change 25.69% 21.54%
LONG-TERM ASSETS
Property, Plant & Equipment $447.9M $255.5M
YoY Change 75.29% 58.05%
Goodwill $91.31M
YoY Change 9.03%
Intangibles
YoY Change
Long-Term Investments $49.13M $41.72M
YoY Change 17.75% -63.14%
Other Assets $19.30M $22.99M
YoY Change -16.05% 218.32%
Total Long-Term Assets $655.6M $548.0M
YoY Change 19.64% 28.67%
TOTAL ASSETS
Total Short-Term Assets $1.261B $1.003B
Total Long-Term Assets $655.6M $548.0M
Total Assets $1.917B $1.551B
YoY Change 23.56% 23.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.74M $45.95M
YoY Change 6.07% 48.59%
Accrued Expenses $196.8M $158.8M
YoY Change 23.87% 47.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $566.6M $424.8M
YoY Change 33.39% 42.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $15.28M $3.522M
YoY Change 333.93% 197.97%
Total Long-Term Liabilities $15.28M $3.522M
YoY Change 333.93% 197.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $566.6M $424.8M
Total Long-Term Liabilities $15.28M $3.522M
Total Liabilities $697.6M $472.9M
YoY Change 47.52% 38.51%
SHAREHOLDERS EQUITY
Retained Earnings $373.4M $232.9M
YoY Change 60.36% 165.82%
Common Stock $8.000K $8.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.219B $1.078B
YoY Change
Total Liabilities & Shareholders Equity $1.917B $1.551B
YoY Change 23.56% 23.97%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income $106.1M $69.18M
YoY Change 53.38% 37.95%
Depreciation, Depletion And Amortization $12.63M $8.876M
YoY Change 42.32% 74.28%
Cash From Operating Activities $139.8M $110.5M
YoY Change 26.52% 45.2%
INVESTING ACTIVITIES
Capital Expenditures -$57.70M -$18.40M
YoY Change 213.59% -2.13%
Acquisitions
YoY Change
Other Investing Activities $2.500M $55.20M
YoY Change -95.47% 2023.08%
Cash From Investing Activities -$55.30M $36.80M
YoY Change -250.27% -327.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.90M -51.20M
YoY Change -39.65% 10.34%
NET CHANGE
Cash From Operating Activities 139.8M 110.5M
Cash From Investing Activities -55.30M 36.80M
Cash From Financing Activities -30.90M -51.20M
Net Change In Cash 53.60M 96.10M
YoY Change -44.22% 611.85%
FREE CASH FLOW
Cash From Operating Activities $139.8M $110.5M
Capital Expenditures -$57.70M -$18.40M
Free Cash Flow $197.5M $128.9M
YoY Change 53.22% 35.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 algn Accrued Sales Return Reserve Current
AccruedSalesReturnReserveCurrent
1364000 USD
CY2018Q2 algn Accrued Sales Return Reserve Current
AccruedSalesReturnReserveCurrent
5554000 USD
CY2017Q4 algn Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
5814000 USD
CY2018Q2 algn Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
2729000 USD
CY2017Q4 algn Deferred Tax Liability Not Recognized Amount That Would Be Due If Earnings Are Distributed
DeferredTaxLiabilityNotRecognizedAmountThatWouldBeDueIfEarningsAreDistributed
3300000 USD
CY2017Q4 algn Accrued Customer Credits
AccruedCustomerCredits
5373000 USD
CY2018Q2 algn Accrued Customer Credits
AccruedCustomerCredits
11552000 USD
CY2017Q4 algn Accrued Expenses
AccruedExpenses
27318000 USD
CY2018Q2 algn Accrued Expenses
AccruedExpenses
36776000 USD
CY2017Q4 algn Accrued Fixed Assets Current
AccruedFixedAssetsCurrent
11362000 USD
CY2018Q2 algn Accrued Fixed Assets Current
AccruedFixedAssetsCurrent
12889000 USD
CY2017Q4 algn Deferred Tax Liability Not Recognized Amountof Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries No Longer Indefinitely Reinvested
DeferredTaxLiabilityNotRecognizedAmountofUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiariesNoLongerIndefinitelyReinvested
591900000 USD
CY2017Q4 algn Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease
FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease
24404000 USD
CY2018Q2 algn Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease
FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease
27729000 USD
CY2017Q4 algn Finite Lived Intangible Assets Accumulated Impairment Loss
FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss
19258000 USD
CY2018Q2 algn Finite Lived Intangible Assets Accumulated Impairment Loss
FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss
19258000 USD
algn Forward Contract Indexedto Issuers Equity
ForwardContractIndexedtoIssuersEquity
15000000 USD
algn Forward Contract Indexedto Issuers Equity
ForwardContractIndexedtoIssuersEquity
0 USD
CY2018Q2 algn Future Amortization Expense Thereafter
FutureAmortizationExpenseThereafter
2434000 USD
CY2017Q2 algn Income Tax Extension Period
IncomeTaxExtensionPeriod
P12Y
CY2017 algn Marketable Securities Weighted Average Remaining Maturity
MarketableSecuritiesWeightedAverageRemainingMaturity
P6M
algn Marketable Securities Weighted Average Remaining Maturity
MarketableSecuritiesWeightedAverageRemainingMaturity
P5M
algn Maturity Period Used To Classify Investments
MaturityPeriodUsedToClassifyInvestments
P40M
CY2018Q2 algn Operating Leases Future Minimum Payments Due Remainder Of Period
OperatingLeasesFutureMinimumPaymentsDueRemainderOfPeriod
9213000 USD
CY2017Q4 algn Other Longterm Assets
OtherLongtermAssets
4821000 USD
CY2018Q2 algn Other Longterm Assets
OtherLongtermAssets
2759000 USD
CY2017 algn Tax Cutsand Jobs Actof2017 Changein Tax Rate Deferred Tax Assetsand Liabilities Income Tax Expense
TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxAssetsandLiabilitiesIncomeTaxExpense
10400000 USD
CY2017 algn Tax Cutsand Jobs Actof2017 Changein Tax Rate Income Tax Expense Benefit
TaxCutsandJobsActof2017ChangeinTaxRateIncomeTaxExpenseBenefit
84300000 USD
algn Tax Cutsand Jobs Actof2017 Changein Tax Rate Income Tax Expense Benefit
TaxCutsandJobsActof2017ChangeinTaxRateIncomeTaxExpenseBenefit
500000 USD
CY2017Q4 algn Tax Cutsand Jobs Actof2017 Transition Taxfor Accumulated Foreign Earnings Liability
TaxCutsandJobsActof2017TransitionTaxforAccumulatedForeignEarningsLiability
73900000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-57000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
782000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7M13D
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001097149
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
80320082 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ALIGN TECHNOLOGY INC
dei Trading Symbol
TradingSymbol
ALGN
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
36776000 USD
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
48744000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
324189000 USD
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
374371000 USD
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
12405000 USD
CY2018Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7764000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
195562000 USD
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
196754000 USD
CY2017Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
11209000 USD
CY2018Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3772000 USD
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6316000 USD
CY2018Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6876000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
571000 USD
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
911000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
886435000 USD
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
844599000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14245000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29057000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16890000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32720000 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3200000 USD
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000 USD
CY2017Q4 us-gaap Assets
Assets
1784009000 USD
CY2018Q2 us-gaap Assets
Assets
1916589000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
1158367000 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
1260999000 USD
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
311979000 USD
CY2018Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
172690000 USD
CY2017Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
272031000 USD
CY2018Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
164629000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
272031000 USD
CY2018Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
164629000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
39948000 USD
CY2018Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
8061000 USD
CY2017Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
39948000 USD
CY2018Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
7947000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5478000 USD
CY2018Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
8061000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20291000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20854000 USD
CY2017Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
5515000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
449511000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
547993000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-34230000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
393019000 USD
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
358789000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
450125000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
548581000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34230000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
98456000 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80040000 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80313000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80040000 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80313000 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
70405000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
139381000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
106678000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
201631000 USD
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
85565000 USD
us-gaap Cost Of Revenue
CostOfRevenue
160281000 USD
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
124677000 USD
us-gaap Cost Of Revenue
CostOfRevenue
234193000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4862000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6145000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3667000 USD
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
267713000 USD
CY2018Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
321148000 USD
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4588000 USD
CY2018Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7625000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
49334000 USD
CY2018Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
45859000 USD
CY2017Q4 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
14700000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15387000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8164000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7703000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10605000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4410000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10743000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
52038000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
44266000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-551000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1610000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-14802000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-53442000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
29580000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
54983000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8616000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15586000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-388000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9366000 USD
CY2017Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
89068000 USD
CY2018Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
85307000 USD
CY2017Q2 us-gaap Interest Income Operating
InterestIncomeOperating
1441000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
2636000 USD
CY2018Q2 us-gaap Interest Income Operating
InterestIncomeOperating
1917000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
4093000 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6810000 USD
CY2018Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11880000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
31688000 USD
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8876000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16743000 USD
CY2018Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12632000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24066000 USD
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.73
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.52
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.70
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.48
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
3640000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1923000 USD
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.177
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.054
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.066
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.049
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
103004000 USD
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
87697000 USD
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
54600000 USD
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
54606000 USD
CY2018Q2 us-gaap Equity Method Investments
EquityMethodInvestments
49100000 USD
CY2018Q2 us-gaap Equity Method Investments
EquityMethodInvestments
49128000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3149000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2116000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3389000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3855000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6184000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
68116000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
68114000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24454000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21127000 USD
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
270917000 USD
us-gaap Gross Profit
GrossProfit
506542000 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
365582000 USD
us-gaap Gross Profit
GrossProfit
692990000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
86781000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
150099000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
117509000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
218054000 USD
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2215000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3336000 USD
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3701000 USD
CY2018Q2 us-gaap Inventory Net
InventoryNet
47252000 USD
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12721000 USD
CY2018Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22976000 USD
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12157000 USD
CY2018Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12396000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
629721000 USD
CY2018Q2 us-gaap Liabilities
Liabilities
697630000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1784009000 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1916589000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
500051000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
566646000 USD
CY2018Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2013Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
10000000 USD
CY2018Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
50000000 USD
CY2013Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000 USD
CY2018Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
200000000.0 USD
CY2017Q4 us-gaap Loans Receivable Net
LoansReceivableNet
30000000 USD
CY2018Q2 us-gaap Loans Receivable Net
LoansReceivableNet
0 USD
CY2017Q4 us-gaap Longterm Purchase Commitment Period
LongtermPurchaseCommitmentPeriod
P4Y
CY2018Q2 us-gaap Longterm Purchase Commitment Period
LongtermPurchaseCommitmentPeriod
P5Y
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-84240000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-170745000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-111718000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
54003000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
158088000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
217121000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
69179000 USD
us-gaap Net Income Loss
NetIncomeLoss
138599000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
106105000 USD
us-gaap Net Income Loss
NetIncomeLoss
201971000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1771000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2221000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7099000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6922000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
187348000 USD
us-gaap Operating Expenses
OperatingExpenses
361300000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
242891000 USD
us-gaap Operating Expenses
OperatingExpenses
472107000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
83569000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
145242000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
122691000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
220883000 USD
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
82248000 USD
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
9617000 USD
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
11827000 USD
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
13503000 USD
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
17350000 USD
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
20738000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5779000 USD
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10633000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
43893000 USD
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19302000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
27000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
42000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-186000 USD
CY2017Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
305200000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1199000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
740000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
759000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-283000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1226000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
573000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-340000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15579000 USD
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15283000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5837000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4543000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2940000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-668000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
38793000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
37968000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
79330000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
212226000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
78405000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8953000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
15000000 USD
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
78045000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
115295000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
80948000 USD
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
126754000 USD
us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
0 USD
us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
30000000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7521000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8585000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
173094000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
207475000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
32352000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
9560000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
348793000 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
447933000 USD
CY2018Q2 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
425900000 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
373441000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24384000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47188000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30804000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60395000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
267274000 USD
CY2018Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
358000000 USD
CY2017Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
5503000 USD
CY2018Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
5955000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
356500000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
356482000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
666823000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
666800000 USD
CY2018Q2 us-gaap Sales Revenue Net
SalesRevenueNet
490259000 USD
CY2018Q2 us-gaap Sales Revenue Net
SalesRevenueNet
490300000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
927183000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
927200000 USD
CY2017Q4 us-gaap Securities Owned Not Readily Marketable
SecuritiesOwnedNotReadilyMarketable
0 USD
CY2018Q2 us-gaap Securities Owned Not Readily Marketable
SecuritiesOwnedNotReadilyMarketable
4862000 USD
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
3557000 USD
CY2018Q2 us-gaap Security Deposit
SecurityDeposit
3734000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
162964000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
314112000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
212087000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
411712000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
29057000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
32720000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.261
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.357
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
14000 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
26.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
78.38
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4651000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
75000 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.36
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.96
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4651000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
14000 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.96
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.13
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y3M18D
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4651000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7M13D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7M13D
CY2016Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3841000 USD
CY2017Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5028000 USD
CY2017Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5929000 USD
CY2018Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7286000 USD
CY2017Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
5929000 USD
CY2018Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
7286000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2503000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
4371000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3690000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5728000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61000 shares
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1154288000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
1218959000 USD
CY2017Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
114091000 USD
CY2018Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
115701000 USD
CY2017Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
606500000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
47700000 USD
CY2018Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
53200000 USD
CY2018Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
3600000 USD
CY2018Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
28000000 USD
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1443000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1621000 shares
CY2018Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1255000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1448000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81631000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81668000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81471000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81575000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80188000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80047000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80216000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80127000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles (&#8220;GAAP&#8221;) in the U.S. requires our management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes.&#160;Actual results could differ materially from those estimates.&#160;On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, valuation of investments in privately held companies, useful lives of intangible assets and property and equipment, revenue recognition, stock-based compensation, long-lived assets and goodwill, income taxes and contingent liabilities, among others.&#160;We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</font></div></div>

Files In Submission

Name View Source Status
0001097149-18-000029-index-headers.html Edgar Link pending
0001097149-18-000029-index.html Edgar Link pending
0001097149-18-000029.txt Edgar Link pending
0001097149-18-000029-xbrl.zip Edgar Link pending
algn-20180630.htm Edgar Link pending
algn-20180630.xml Edgar Link completed
algn-20180630.xsd Edgar Link pending
algn-20180630xex311.htm Edgar Link pending
algn-20180630xex312.htm Edgar Link pending
algn-20180630xex321.htm Edgar Link pending
algn-20180630_cal.xml Edgar Link unprocessable
algn-20180630_def.xml Edgar Link unprocessable
algn-20180630_lab.xml Edgar Link unprocessable
algn-20180630_pre.xml Edgar Link unprocessable
chart-8022e3cf1db05df0900a01.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending